VRXA

Veraxa Biotech AG - Ordinary Shares (VRXA)

About Veraxa Biotech AG - Ordinary Shares (VRXA)

Veraxa Biotech Holding AG engages in operating an oncology-focused biotechnology company, which is the Veraxa Biotech AG (Company). The Company focuses on the development of novel antibody-based drug platforms for the treatment of cancer. The company was founded on June 25, 2025 and is headquartered in Zurich, Switzerland.

Details

Daily high

$1.72

Daily low

$1.62

Price at open

$1.68

52 Week High

$27.36

52 Week Low

$1.27

Market cap

243.8M

Dividend yield

Volume

88,877

Avg. volume

428,408

P/E ratio

7.70

Veraxa Biotech AG - Ordinary Shares News